Ovarian Cancer Research Program Pilot Award

Objecte

The FY13 appropriation is $20M. The overall goal of the FY13 OCRP is to eliminate ovarian cancer by supporting innovative, high-impact research. The OCRP’s long-term priorities are:
• Understand precursor lesion/stem cell, microenvironment, and pathogenesis/ progression of ovarian cancer;
• Improve performance and reliability of disease markers and imaging toward screening and selecting the best therapeutic approaches;
• Address issues in survivorship;
• Enhance pool of ovarian cancer scientists; and
• Investigate tumor response to therapy including tumor survival, dormancy, cell death, clonal evolution, tumor heterogeneity.

The OCRP Pilot Award supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer research forward. The proposed research should include a testable hypothesis based on strong scientific rationale and serve as a catalyst to expand or modify current thinking about and/or approaches in ovarian cancer research. Preliminary data are not required, but are allowed. The strength of the application should be based on sound scientific rationale and logical reasoning. Clinical trials will not be supported by this award mechanism.

Termini IISPV

Cal comunicar abans del 30 de maig 2013 que es vol participar a la convocatòria, enviant un e-mail a europa@iispv.cat . Termini: 06 de juny de 2013

Termini Oficial

Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), June 12, 2013
Invitation to Submit an Application: July 2013
Application Submission Deadline: 11:59 p.m. ET, August 28, 2013
Peer Review: October 2013
Programmatic Review: December 2013

Estàs interessat?

Omple el següent formulari per rebre més informació: